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http://dx.doi.org/10.1016/j.asjsur.20
1015-9584/Copyright ª 2016, Asian SuSummary Objective: We applied carbon nanoparticle suspensions to the papillary thyroid
carcinoma cases with no clinical regional lymph node metastasis (cN0) to show the lymph flow
from primary tumors, and evaluated its value in the lymph node biopsy of cN0 papillary thyroid
carcinoma and protection of parathyroid.
Patients and methods: One hundred and fourteen patients with cN0 papillary thyroid carci-
noma were randomly assigned to experimental and control groups. The experimental group
received carbon nanoparticles injection around the primary tumor, while the control group
received no injection. Both groups subsequently received standard lateral thyroid gland resec-
tion, isthmus resection, subtotal thyroidectomy, or clearance of lymph nodes (LNs) of the cen-
tral compartment.
Results: A total of 342 LNs of the central compartment were dissected in the experimental
group (6.00  0.98 per patient) with 81 LNs confirmed to be positive (0.95  0.77 per patient),
whereas 261 LNs of the same area were dissected in the control group (4.58  0.60 per patient)
with 27 confirmed to be positive (0.47  0.50 per patient). There is a significant difference be-
tween experimental and control groups in the average number of LNs dissected per patient
(6.00  0.98 vs. 4.58  0.60, p < 0.001) but not the positive LNs per patient (0.95  0.77
vs. 0.47 0.50, pZ 0.11). Parathyroid was found in two patients from the experimental group
and in seven patients in the control group (pZ 0.29). Three patients in the experimental group
and seven patients in the control group had hypocalcemia (pZ 0.21), and four patients in eachcertify that they have no affiliations with or involvement in any organization or entity with any
educational grants, participation in speakers’ bureaus, membership, employment, consultancies,
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filiations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
of General Surgery, Jin Ling Hospital, Clinical School of Medical College of Nanjing University, Nanjing
mail.com (J. Gu).
XF, Gu J, The application of carbon nanoparticles in the lymph node biopsy of cN0 papillary thyroid
clinical trial, Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.asjsur.2015.11.004
15.11.004
rgical Association. Published by Elsevier Taiwan LLC. All rights reserved.
2 X.F. Xu, J. Gu
+ MODELPlease cite this article in press as: Xu
carcinoma: A randomized controlledgroup had hoarseness (p Z 0.58).
Conclusions: Carbon nanoparticle suspensions can be used to stain central lymph nodes of cN0
papillary thyroid carcinoma without staining of parathyroid and leakage, and improve the
resection of LNs.
Copyright ª 2016, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Thyroid cancer is a common type of malignant cancer in the
head and neck area. Most thyroid cancer cases are differ-
entiated thyroid carcinoma, including papillary thyroid
carcinoma (PTC) and follicular thyroid carcinoma, with PTC
accounting for 60e70% of cases. With improved health
status and detection technology, PTC with no clinical
regional lymph node metastasis (cN0) becomes increasingly
common, making it important to improve the treatment of
this disease.
Surgery is the most popular treatment choice of PTC,
with complete resection of the lateral thyroid gland,
isthmus, and subtotal thyroidectomy. The current
consensus treatment for patients with positive cervical
lymph node (LN) and LN metastasis is complete resection of
the tumor and cervical LNs. However, whether this treat-
ment is necessary for cN0 PTC is still disputable.1 It was
reported that 40% to 60% of LNs resected could be positive,
supporting the need for complete removal of all cervical
LNs to prevent the risk of cancer recurrence and treatment
failure.2,3
With technical improvements, the focus of thyroid sur-
gery is gradually changing from the protection of recurrent
laryngeal nerve injury to protection of the parathyroid.
Parathyroid is located on the inside lobes of the thyroid,
and its number is variable. The position of the superior
parathyroid is relatively stable and easy to preserve in situ
during surgery. On the contrary, the location of the inferior
parathyroid can be varied and accidentally removed as LNs
during central LNs dissection. It was reported that 6.9% to
46% of thyroid surgery resulted in parathyroid damage.4 In
light of this, the best practice is to preserve the parathyroid
during thyroid surgery to avoid damage to parathyroid
functions.5
Carbon nanoparticles suspensions (CNS) injection has
been applied as a new LN biopsy tracer with high specificity
for the lymph system. Compared with traditional dye,
carbon nanoparticles (CNs) have the advantages of a long
retention time in the lymph system, low toxicity, and
exclusion from blood circulation. Moreover, CNs usually do
not stain the parathyroid, providing better demarcation of
the parathyroid. The CNs in tissue can be subsequently
removed together with the thyroid tissue and LNs, while
the remaining CNs are captured by macrophages and
excreted through the lungs, kidneys, and intestines after a
few months.6 Further, CNs do not interfere with patho-
logical examination of stained tissue because they can not
be detected with optical microscopy due to their small
size.XF, Gu J, The application of carb
clinical trial, Asian Journal of SuHere we carried out a random controlled study of the
application of CNS to cN0 papillary thyroid carcinoma sur-
gery. Patients with cN0 papillary thyroid carcinoma treated
at our hospital were randomly assigned to control and
experimental groups. Patients in the experimental group
were injected with CNS while patients in the control group
received no injection. The amount of LNs, positive LNs,
parathyroid, pre- and post-operative serum parathyroid
hormone, pre- and post-operative serum calcium, and the
number of patients with hypocalcemia and postoperative
hoarseness were statistically analyzed between experi-
mental and control groups. The value of CNS in sentinel LN
biopsy and protection of the parathyroid in cN0 papillary
thyroid carcinoma surgery was evaluated.
2. Patients and methods
2.1. Patients
One hundred fourteen patients with cN0 papillary thyroid
carcinoma who sought treatment at our hospital between
September 1, 2013 and August 31, 2014 were included in
this study, including nine men and 105 women (16e60 years
of age). This study was approved by the Institutional Review
Board of Jinling Hospital. All patients were informed of the
approach and risk of this treatment and signed the consent.
Patients were randomly assigned into experimental and
control groups.
Patients who met the following criteria were recruited:
(1) diagnosis of papillary thyroid carcinoma by ultrasound
guided fine needle aspiration; (2) meet cN0 stage standard
(no clinical regional LN metastasis and no LNs larger than
1 cm detected using imaging); (3) no history of thyroid
surgery or neck irradiation; (4) no hypocalcemia or numb-
ness or spasms of limbs; (5) surgery was performed by the
same group of surgeons; and (6) no sign of blood coagula-
tion dysfunction.
2.2. Imaging agents
CNS was purchased from Chongqing Lummy Pharmaceutical
Co. Ltd. (China) under the name Carbon Nanoparticle Sus-
pension Injection.
2.3. Surgical procedure
All patients received the same surgical procedure. An
incision was made through the skin and the platysma. Flap
separation was performed before making an incision in theon nanoparticles in the lymph node biopsy of cN0 papillary thyroid
rgery (2016), http://dx.doi.org/10.1016/j.asjsur.2015.11.004
Table 1 Patient information.
Variable Experimental
N Z 57
Control
N Z 57
p
Sex (M/F) 5/52 4/53 0.55
Age (yr) 45.37  10.71 42.68  14.43 0.52
Tumor size (mm) 10.68  4.39 10.32  5.47 0.82
LNs (n) 6.00  0.98 4.58  0.60 <0.001
Positive LNs (n) 0.95  0.77 0.47  0.50 0.11
Parathyroid (n) 2/57 7/57 0.29
Hypocalcemia (n) 3/57 9/57 0.21
Hoarseness (n) 4/57 4/57 0.58
Pre-op PTH (pmol/L) 4.68  2.16 5.06  2.03 0.29
Postop PTH (pmol/L) 4.89  1.80 4.53  2.05 0.82
Pre-op serum Ca
(mmol/L)
2.36  0.16 2.37  0.13 0.87
Postop serum Ca
(mmol/L)
2.17  0.21 2.09  0.22 0.46
Ca Z calcium; F Z female; LN Z lymph node; M Z male;
PTH Z parathyroid hormone.
Figure 1 Sentinel lymph node detected using carbon nano-
particle suspensions. Sentinel lymph nodes were stained black
after injection of carbon nanoparticle suspensions (arrow).
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fully dissociated without injury to the capsule to expose
the thyroid gland. Using a 1-mL syringe and a 27-gauge
needle, approximately 0.5 mL CNs was injected into the
thyroid tissue surrounding the primary tumor. Caution
should be taken to avoid the entrance of CNs into blood
vessels. Within 5e10 minutes, the stained LNs in the cen-
tral compartment were imaged. The control group
received no injection of CNs or other dyes. Both groups
subsequently received standard lateral thyroid gland
resection, isthmus resection, subtotal thyroidectomy, or
node clearance of LNs of central compartments. During the
surgery, the parathyroid needs to be carefully dissociated
and exposed.
Node clearance of the central cervical compartment was
performed cranially to thyroid cartilage, caudally to the
thymus, laterally to the medial margin of carotid sheaths,
including anterior of pretracheal, paratracheal, and
delphian LNs. All thyroidectomy and neck dissection spec-
imens were sent for pathological examination.
All experimental data were carefully recorded, including
the total number of all excised LNs and the positive LNs,
number of parathyroid, pre- and post-operative serum
parathyroid hormone, pre- and post-operative serum cal-
cium, and the number of patients with hypocalcemia and
postoperative hoarseness.
2.4. Statistical methods
All statistical analyses were performed using SPSS 18.0
software (SPSS Inc., Chicago, IL, USA). Measurements were
reported as mean  standard deviation. Continuous mea-
surements were compared with t test and the count data
analyzed using the Chi-square test. A p value < 0.05 was
considered to indicate statistical significance.
3. Results
After diagnosed of cN0 papillary thyroid carcinoma using
fine needle biopsy, all qualified patients were randomly
assigned to experimental and control groups. In total, 114
patients were recruited into this study and evenly split into
experimental and control groups with 57 patient in each
group. No significant difference was observed between
these two groups in major variables, such as age, sex, and
tumor size (Table 1).
In the experimental group, 342 LNs of the central
compartment were dissected, with an average of
6.00  0.98 per patient. Among them, 81 LNs were
confirmed to be positive, with an average of 0.96  0.77 per
patient. The positive rate is 23.68%. Two hundred and sixty
one LNs of the same area were dissected in the control
group with an average of 4.58  0.60 per patient. Among
them, 27 were confirmed to be positive with an average of
0.47  0.50 and a positive rate of 10.34%. The number of
LNs dissected from the experimental group was significantly
higher than that of the control group (p < 0.001). The
number of positive LNs was also higher in the experimental
group, but the difference was not statistically significant
(p Z 0.11; Table 1). The LNs in the experimental group
were stained black by CNS (Figure 1).Please cite this article in press as: Xu XF, Gu J, The application of carb
carcinoma: A randomized controlled clinical trial, Asian Journal of SuPathological examination identified parathyroid tissue in
dissected tissues from two patients in the experimental
group and seven patients in the control group, but the
difference was not significant (Chi-square p Z 0.29; Table
1). The parathyroid tissues from the experimental groups
were not stained. Transient hypocalcemia was observed in
three patients from the experimental group while nine
patients from the control group showed transient hypocal-
cemia. However, the difference was not significant (Chi-
square pZ 0.21; Table 1). Hypocalcemia patients received
a calcium supplement with a gradual dose reduction for
2e3 weeks. All patients had normal blood calcium levels at
recheck. Four patients from the experimental group and
four patients from the control group had postoperative
hoarseness with no statistical significance (Chi-square
p Z 0.58; Table 1). All patients with hoarseness recovered
without treatment within 2e3 weeks.
There was no significant difference between experi-
mental and control groups in terms of pre-operative serum
parathyroid hormone (PTH) level (pZ 0.29), postoperative
serum PTH level (p Z 0.82), pre-operative serum calciumon nanoparticles in the lymph node biopsy of cN0 papillary thyroid
rgery (2016), http://dx.doi.org/10.1016/j.asjsur.2015.11.004
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Table 1).4. Discussion
The parathyroid is located on the backside of thyroid with
varying numbers. The positions of the inferior parathyroid
glands usually show more variation than those of the su-
perior parathyroid glands, and may be accidentally
removed as LNs. It is reported that 6.9% to 46% of para-
thyroid glands were damaged during thyroid surgery.4
Because of the possible hypocalcemia resulting from the
loss of parathyroid glands, the best practice is to preserve
the parathyroid as well as possible during thyroid surgery to
avoid damage to parathyroid functions.5
The popular methods for staining of LNs are blue dye
method, radioisotope method, and combined positioning
method. The common dyes used for staining of LNs include
isosulfan blue, patent blue, and methylene blue (MB). They
are easy to apply and have no radioactivity. However, MB
can enter blood capillary as well as lymphatic capillary and
cause the staining of surrounding tissues. This may mask the
existence of stained LNs and result in the accidental
dissection of the parathyroid gland.7 Moreover, the recur-
rent laryngeal nerve may also be stained and incur acci-
dental injury during surgery. Radioisotope and combined
positioning use radioactive isotopes and need special in-
struments, which limit their applications.
With the introduction of nanotechnology, CNS injection
was successfully produced and applied to clinical detection
of LNs. CNS is a black suspension injection prepared by
mixing active carbon nanoparticles with suspending agent
polyvinylpyrrolidone and physiological saline.8 CNS has high
specificity for the lymphatic system as a lymph tracer. The
average diameter of CNs is 150 nm, making it possible to
enter the lymphatic capillary with an average epithelial gap
of 120 nm to 500 nm but not the blood capillary with an
average epithelial gap of 20 nm to 50 nm. Upon entering the
lymphatic system, CNs can aggregate in the LNs, causing
staining of the LNs but not neighboring tissues, especially
the parathyroid gland.9 Further, CNs have a longer reten-
tion time in LNs, providing ample time for surgeons to
identify and dissect LNs. By using CNS as a lymph node
tracer, only LNs are stained but not the parathyroid glad,
resulting in so-called “negative staining”. This enables the
efficient identification and clearance of LNs and optimum
preservation of the parathyroid gland.
CNS is a nontoxic and safe reagent, with no mutagenicity
and carcinogenicity detected in animal experiments.10 It
also has no obvious effects on central nerve system, car-
diovascular system, and respiratory system.11 Clinical
application of CNS showed no toxicity so far.12 Injected CNs
are subsequently removed with the dissection of thyroid
tissue and LNs, with the remaining CNs are captured by
macrophages and excreted through the lungs, kidneys, and
intestines in a few months.6
Hao et al12 compared the efficacies of CNS and MB as
sentinel LN tracers in the papillary thyroid microcarcinoma
surgery of 200 patients. The total number of sentinel LNs
dissected in the CNS group was 1119, among which 110 were
positive and 102 were stained. Whereas in the MB group, thePlease cite this article in press as: Xu XF, Gu J, The application of carb
carcinoma: A randomized controlled clinical trial, Asian Journal of Sutotal number was 1024, with 99 positive and 85 stained. The
positive rate was 61.1% for CNS group, which is significantly
higher than the rate of 47.1% for the MB group. Significantly
better results were observed in the CNS group compared
with the MB group in the percentage of positive dissected
LNs, specificity, accuracy, and false positive rate. CNS was
not only useful for clearance of LNs in the central com-
partments, but also for lateral cervical LNs. Wu et al13 re-
ported that CNS was helpful for detection of lateral cervical
LNs during endoscope assisted lower neck region lymph node
dissection in 26 patients with papillary thyroid carcinoma.
In this study, thyroid and surrounding LNs were effec-
tively stained by CNS, while other surrounding tissues,
parathyroid gland, the recurrent laryngeal nerve were not
stained. The experimental group has average LNs of
6.00  0.98, significantly more than 4.58  0.60 of the
control group. This is in agreement with other reports. The
experimental group also showed a higher percentage of
metastatic LNs (23.68%) than the control group (10.34%), but
no statistical significance was observed possibly due to small
sample size. Although the experimental group also showed
better results in the numbers of cases of postoperative
hoarseness, serum PTH, and serum calcium compared with
control group, no significant difference was observed. A
larger study is needed to confirm these findings.
Of course, attention needs to be paid to certain tech-
niques for CNS injection in thyroid cancer surgery. For
example, the injection needs to be made to the thyroid
tissue near the tumor. Caution has to be used not to disso-
ciate the thyroid too much to avoid injury to the capsule
which may interfere with lymph reflux. Injection of CNS
should avoid accidental introduction of CNS into the blood
vessel. The injection point needs to be sutured or pressed
with gauze to avoid leakage of CNS into the field of surgery.
The thyroid is then returned to the original position after
injection and dissection is performed after 5e10 minutes.5. Conclusion
Application of CNS to LN biopsy of cN0 papillary thyroid
carcinoma can stain the LNs of the center compartment
while leaving the parathyroid glands unstained, facilitating
the identification and clearance of LNs. A future study with
more patients and longer term of follow-up will be carried
out in our hospital to further evaluate the value of CNS in
LN biopsy and reduction of LN recurrence of cN0 papillary
thyroid carcinoma.References
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